These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Tumours of the liver. Frith CH; Ward JM; Turusov VS IARC Sci Publ; 1994; (111):223-69. PubMed ID: 8082908 [No Abstract] [Full Text] [Related]
7. Inherent increase of apoptosis in liver tumors: implications for carcinogenesis and tumor regression. Grasl-Kraupp B; Ruttkay-Nedecky B; Müllauer L; Taper H; Huber W; Bursch W; Schulte-Hermann R Hepatology; 1997 Apr; 25(4):906-12. PubMed ID: 9096596 [TBL] [Abstract][Full Text] [Related]
8. The role of cytokines in hepatocellular carcinoma. Budhu A; Wang XW J Leukoc Biol; 2006 Dec; 80(6):1197-213. PubMed ID: 16946019 [TBL] [Abstract][Full Text] [Related]
9. Hepatocellular carcinoma--a model of human cancer: clinico-pathological features, etiology and pathogenesis. Nayak NC Indian J Pathol Microbiol; 2003 Jan; 46(1):1-16. PubMed ID: 15027710 [TBL] [Abstract][Full Text] [Related]
11. [p53 gene mutation in hepatocellular carcinoma]. Jiang W; Lu Q; Pan G Zhonghua Wai Ke Za Zhi; 1998 Sep; 36(9):531-2. PubMed ID: 11825456 [TBL] [Abstract][Full Text] [Related]
13. Molecular pathogenesis of hepatocellular carcinoma. McKillop IH; Moran DM; Jin X; Koniaris LG J Surg Res; 2006 Nov; 136(1):125-35. PubMed ID: 17023002 [TBL] [Abstract][Full Text] [Related]
14. Characterization and prevalence of a polymorphism in the 3' untranslated region of cytochrome P4501A1 in cancer-prone Atlantic tomcod. Roy NK; Kreamer GL; Konkle B; Grunwald C; Wirgin I Arch Biochem Biophys; 1995 Sep; 322(1):204-13. PubMed ID: 7574676 [TBL] [Abstract][Full Text] [Related]
15. Molecular therapy and prevention of hepatocellular carcinoma. Blum HE Hepatobiliary Pancreat Dis Int; 2003 Feb; 2(1):11-22. PubMed ID: 14599923 [TBL] [Abstract][Full Text] [Related]
16. The pathogenesis of hepatocellular carcinoma is multifactorial event. Novel immunological treatment in prospect. Marotta F; Vangieri B; Cecere A; Gattoni A Clin Ter; 2004 May; 155(5):187-99. PubMed ID: 15344567 [TBL] [Abstract][Full Text] [Related]
17. Impact of etiology of cirrhosis on the survival of patients diagnosed with hepatocellular carcinoma during surveillance. Trevisani F; Magini G; Santi V; Morselli-Labate AM; Cantarini MC; Di Nolfo MA; Del Poggio P; Benvegnù L; Rapaccini G; Farinati F; Zoli M; Borzio F; Giannini EG; Caturelli E; Bernardi M; Am J Gastroenterol; 2007 May; 102(5):1022-31. PubMed ID: 17313497 [TBL] [Abstract][Full Text] [Related]
18. Hepatocellular carcinoma and nodular regenerative hyperplasia: possible pathogenetic relationship. Nzeako UC; Goodman ZD; Ishak KG Am J Gastroenterol; 1996 May; 91(5):879-84. PubMed ID: 8633575 [TBL] [Abstract][Full Text] [Related]
19. Genes involved in hepatocellular carcinoma: deregulation in cell cycling and apoptosis. Tannapfel A; Wittekind C Virchows Arch; 2002 Apr; 440(4):345-52. PubMed ID: 11956813 [TBL] [Abstract][Full Text] [Related]
20. Hepatocellular carcinoma in black-tailed prairie dogs (Cynomys ludivicianus): tumor morphology and immunohistochemistry for hepadnavirus core and surface antigens. Garner MM; Raymond JT; Toshkov I; Tennant BC Vet Pathol; 2004 Jul; 41(4):353-61. PubMed ID: 15232135 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]